Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

ASCEND PLUS is a UK-wide clinical trial testing a tablet medication called oral semaglutide, which might help to protect against heart attacks, strokes and circulatory problems in people with type 2 diabetes.

The study, run by the University of Oxford, will include 20,000 people with type 2 diabetes.